Literature DB >> 3098455

Does testosterone affect the normal menstrual cycle?

P Dewis, M Newman, W A Ratcliffe, D C Anderson.   

Abstract

In order to throw further light on the role of androgens in the aetiology of the polycystic ovary syndrome (PCO) we have examined the effect of artificially increasing serum testosterone levels on menstrual function in a group of ovulating women. Six women were studied who had either severe premenstrual syndrome or loss of libido for which they were treated with 100 mg testosterone by s.c. implantation. All had regular menstrual cycles. For 1 month before implantation serum LH, FSH, oestradiol (E2), progesterone and testosterone were measured three times per week. All women showed normal cyclical variation of LH, FSH, E2 and progesterone. Following implantation, three times weekly blood samples were taken during the first and third cycles. No patient had any disturbance of menstrual pattern. All continued to show cyclical changes of LH, FSH, E2 and progesterone. Serum E2 and progesterone were lower but not significantly so in the luteal phase of the treated cycles. This was despite a mean serum testosterone which rose from 1.3 to 7.1 nmol/l at the end of the third week following implantation and to 4.1 nmol/l at the end of the third month. Sex hormone binding globulin levels fell as expected by 18.5% during the first cycle. The lack of significant effect of a markedly elevated serum testosterone level on cyclical hormone changes is indirect evidence that in PCO the primary cause of the menstrual disturbance is not excessive production of ovarian or adrenal testosterone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098455     DOI: 10.1111/j.1365-2265.1986.tb03280.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

Authors:  Robert L Rosenfield; Brian Bordini
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

2.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Authors:  A Bachelot; K Laborde; J L Bresson; G Plu-Bureau; A Raynaud; X Bertagna; A Mogenet; M Mansour; V Lucas-Jouy; J-P Gayno; Y Reznik; J-M Kuhn; L Billaud; M-C Vacher-Lavenu; M Putterman; I Mowszowicz; P Touraine; F Kuttenn
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

3.  Serum and follicular fluid sex hormone-binding globulin in stimulated and unstimulated cycles.

Authors:  I Phocas; T Mantzavinos; A Sarandakou; F Dimitriadou; P A Zourlas
Journal:  J Assist Reprod Genet       Date:  1995-07       Impact factor: 3.412

4.  Association of testosterone levels and future suicide attempts in females with bipolar disorder.

Authors:  Leo Sher; Michael F Grunebaum; Gregory M Sullivan; Ainsley K Burke; Thomas B Cooper; J John Mann; Maria A Oquendo
Journal:  J Affect Disord       Date:  2014-05-05       Impact factor: 4.839

Review 5.  The consequences of hyperandrogenism in young women.

Authors:  D R London
Journal:  J R Soc Med       Date:  1987-12       Impact factor: 18.000

6.  Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages.

Authors:  Bindu Kulshreshtha; Marumudi Eunice; Ariachery C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2012-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.